AI Summary & Key Takeaways
AI InsightIt was detected that Anti-HCV reactive patients underwent dialysis for more than five years and they had a lower mean age (p
📌 3 Key Takeaways
Abstract
INTRODUCTION: It was aimed to examine the blood-borne infections in patients to whom hemodialysis is applied due to chronic renal failure and evaluating the effectiveness of infection control programs in this study. MATERIALS AND METHODS: Patients who underwent routine hemodialysis between January and August 2018 were included into the study. The study was designed as a retrospective. The blood samples taken from patients during their health screenings were tested with the macro ELISA method for HBsAg, Anti-HBs, AntiHCV and Anti-HIV observations at the microbiology laboratory and the clinical information was acquired from patient files. RESULTS: There were no patients who developed reactivity of chronic HBsAg and anti-HIV based on dialysis. One of eight AntiHCV reactive patients was not included in the analyses since the patient had the disease before undergoing dialysis. It was detected that Anti-HCV reactive patients underwent dialysis for more than five years and they had a lower mean age (p
Özet
AMAÇ: Bu çalışmada, kronik böbrek yetmezliği tanısıyla hemodiyalizuygulanan hastalarda; kan yoluyla bulaşan enfeksiyonlar incelenerekenfeksiyon kontrol programlarının etkinliğinin değerlendirilmesiamaçlanmıştır.GEREÇ VE YÖNTEM: Çalışmada 1 Ocak- 1 Ağustos 2018 tarihleriarasında rutin hemodiyaliz uygulanan hastaların dosyaları restrospektifolarak incelendi. Hastaların demografik özellikleri ve hastanemizmikrobiyoloji laboratuvarında macro ELİSA yöntemi ile çalışılanHBsAg, Anti-HBs, Anti-HCV ve Anti-HİV serolojileri kaydedildi.BULGULAR: Hemodiyaliz sonrası HBsAg ve Anti-HİV reaktifliğigelişen hasta bulunmamakta olup; Anti-HCV reaktifliği olan yedihasta saptandı. Anti-HCV reaktif hastaların beş yıldan daha uzundiyalize girdiği ve yaş ortalamalarının daha düşük olduğu saptandı(p